Loading…
Attending this event?
View analytic
Tuesday, June 20 • 10:30am - 11:45am
#229: Outcomes Standardization: An Imperative to Value Assessments

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-559-L04-P; CME 1.25; IACET 1.25; RN 1.25

Data from both premarket and postmarketing clinical trials and formal registries of medical products can be used to assess safety and effectiveness across the medical product life cycle. Sources outside of clinical trials, such as EHRs, can provide evidence of continued effectiveness when used in larger populations in the postmarketing setting. However, the lack of consistent outcome assessments is a potential barrier to evaluating safety and efficacy across the continuum of the product life cycle.

Learning Objectives

Discuss the gaps and challenges in the current environment resulting from a lack of outcomes standardization.

Chair

Richard Gliklich, MD

Speaker

Standardizing Outcomes for Patient Registries: Early Results From the Outcome Measures Framework Pilot Test
Elise Berliner, PhD

Panelist
Paul Stang, PhD, FISPE

Panelist
John H. Powers, III, MD, FACP



Moderators
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1
Dr. Richard Gliklich is the CEO of OM1, Inc., a company focused on outcomes measurement and personalization of big data for health care. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles. A graduate of Yale University... Read More →

Speakers
EB

Elise Berliner

Director, Technology Assessment Program, Agency For Healthcare Research and Quality (AHRQ)
Elise Berliner, Ph.D., is the Director of the Technology Assessment Program at AHRQ which provides technology assessments to Medicare to inform coverage decisions and other policy issues. Prior to joining AHRQ, Dr. Berliner worked as a consultant on cost-effectiveness and outcome... Read More →
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1
Dr. Richard Gliklich is the CEO of OM1, Inc., a company focused on outcomes measurement and personalization of big data for health care. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles. A graduate of Yale University... Read More →
avatar for John Powers

John Powers

Professor of Clinical Medicine, George Washington University School of Medicine
Dr. Powers is a physician/investigator and an internist and specialist in infectious diseases. Dr Powers has particular expertise in the design, conduct and analysis of clinical trials and has published numerous articles and book chapters in this area.
avatar for Paul Stang

Paul Stang

Vice President: Global Epidemiology, Janssen Research & Development, LLC
Currently VP Global Epidemiology at J&J; formerly VP Cerner Corporation, which he joined after co-founding and serving as CSO Galt Associates. Worked at Glaxo and SmithKline Beecham as well as clinical appointments in Neurology and Neurosurgery. Published widely in epidemiology wit... Read More →


Tuesday June 20, 2017 10:30am - 11:45am
N426c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616